Stockscreener 앱 받기
1.47%
시간 외 거래:
전일 마감가:
$1.70
열려 있는:
$1.71
하루 거래량:
159.96K
Relative Volume:
0.60
시가총액:
$97.33M
수익:
$16.45M
순이익/손실:
$-73.60M
주가수익비율:
-1.3482
EPS:
-1.2795
순현금흐름:
$-46.25M
1주 성능:
-0.86%
1개월 성능:
-17.46%
6개월 성능:
-21.59%
1년 성능:
-4.70%
1일 변동 폭
$1.7066
$1.77
1주일 범위
$1.67
$1.77
52주 변동 폭
$1.62
$2.41
시어 Stock (SEER) Company Profile
명칭
Seer Inc
전화
650-453-0000
주소
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.725 | 95.92M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
시어 Stock (SEER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-08-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-12-29 | 개시 | BofA Securities | Neutral |
| 2020-12-29 | 개시 | Cowen | Outperform |
| 2020-12-29 | 개시 | JP Morgan | Overweight |
| 2020-12-29 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
시어 주식(SEER)의 최신 뉴스
US Market Wrap: Should you avoid Seer Inc stock right now2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER.O Technical Analysis & Stock Price Forecast - Intellectia AI
Retail Trends: What is the target price for Seer Inc stockProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Seer Inc stock (ISIN: US8158581079) gains traction as protein-analysis platform expands clinical ado - AD HOC NEWS
Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing - Minichart
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit - Investing.com India
Seer Amends Tax Benefit Plan After Stockholder Challenge - TipRanks
Seer (NASDAQ: SEER) updates tax benefit plan after Delaware action - Stock Titan
Aug PostEarnings: Will Seer Inc stock recover after earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Setup Watch: What is the target price for Seer Inc stock2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Sectors: Is now the right time to enter Seer IncWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Sentiment Watch: Whats the fair value of AEV CL stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Sectors Review: Can Seer Inc be recession proof2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
SEER: Strong growth, innovation, and new detector tech set the stage for future expansion - TradingView
Bradley Radoff Sends Open Letter to Seer, Inc. - marketscreener.com
Seer (SEER) Stockholders Express Concerns Over Management and Fi - GuruFocus
Incorrect alert on Seer Inc's forecast withdrawn - marketscreener.com
Radoff-Jec Group calls on Seer board to announce sale process - marketscreener.com
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Stock Titan
Seer shareholder group sends letter to Seer independent directors - TipRanks
SEER Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activist group in Seer (SEER) reports 7.6% stake and opposes NOL pill - Stock Titan
Seer (NASDAQ: SEER) expands Proteograph platform and targets $30B proteomics market - Stock Titan
Seer 10-K: Revenue $16.58M, EPS $(1.28) - TradingView
Seer Inc. Balances Growth Momentum With Cautious Outlook - The Globe and Mail
Seer, Inc. (NASDAQ:SEER) Q4 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Seer Q4 Earnings Call Highlights - Yahoo Finance
Seer, Inc. (NASDAQ:SEER) Short Interest Up 126.6% in February - MarketBeat
Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding Challenges - GuruFocus
SEER Technical Analysis & Stock Price Forecast - Intellectia AI
Seer, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-02-27 - Seeking Alpha
Seer (SEER) Q4 2025 Earnings Call Transcript - AOL.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Seer Adopts Tax Benefit Plan to Protect NOLs - TipRanks
Seer Inc. (NASDAQ:SEER) Shares Plunge on Weak 2026 Revenue Guidance - ChartMill
SEER: 2025 revenue rose 17% to $16.6M, but 2026 growth is tempered by funding headwinds - TradingView
Seer (NASDAQ:SEER) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings call transcript: Seer Inc. reports Q4 2025 earnings beat, stock dips - Investing.com Australia
SEER: 2025 revenue rose 17% to $16.6M, but 2026 guidance remains cautious amid funding uncertainty - TradingView
Q4 2025 Seer Inc Earnings Call Transcript - GuruFocus
Seer Q4 Earnings Summary & Key Takeaways - Benzinga
Seer, Inc. Adopts Tax Benefit Preservation Plan to Protect Income Tax Net Operating Losses - Quiver Quantitative
Seer (SEER) sets 4.9% tax benefit rights plan with $11 exercise price - Stock Titan
SEER: 2025 revenue rose 17% year-over-year, with improved margins and a strong liquidity position - TradingView
시어 (SEER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):